Introduction
In humans, IgE is the principal antibody involved in antigenprovoked mediator release from the lung and appears important in the pathogenesis of asthma (1) (2) . The guinea pig has long been used as a model of human asthma since the airways from the two species respond in a similar way to a variety ofcontractile and relaxant substances (3) . Furthermore, antigen-induced contraction of airway smooth muscle from the two species has been suggested to involve similar primary mediators-histamine and slow reacting substance of anaphylaxis (4) (5) (6) (7) (8) . Unlike humans, however, the major homocytotropic antibody of the guinea pig is IgG, (9) (10) (11) .
The guinea pig, suitably sensitized, is known to be capable of producing IgE antibody (12) (13) (14) (15) . Guinea pig IgE is similar to human IgE in the length oftime it persists in skin after passive sensitization and in loss ofactivity after reduction and alkylation or heat treatment (16) . However, guinea pig IgE has been difficult to study because ofthe lack ofa myeloma protein in this species.
Several recent studies have used the guinea pig, actively sensitized for the production of IgE antibody, as a model of human IgE-mediated pulmonary responses (17) (18) (19) (20) (21) . A drawback to these studies is the fact that both IgE and IgG, antibodies are produced to the antigen with the immunization protocol (17, 18) . Therefore, in an actively sensitized animal, it is difficult to determine the contribution ofeach antibody to specific antigen responses.
We have produced IgE antibody in guinea pigs by pretreating the animals with cyclophosphamide and immunizing with low doses of antigen in alum (22) . Furthermore, the IgE and IgG, antibodies have been successfully separated by affinity chromatography (22) , and the IgE antibody was demonstrated to mediate cutaneous basophil hypersensitivity (23) and histamine release from circulating basophils (24) Preparation ofhapten-protein conjugates. An ascaris protein extract was prepared from a homogenized dessicate of whole worms (George S. Tulloch and Associates, San Antonio, TX) (22) . To conjugate picryl or oxazolone groups to ascaris proteins, 10 ml of the extract at 10 mg/ ml was adjusted to pH 9.0 by addition of 5% Na2CO3. Then, 0.5 ml of 10% picryl chloride or oxazolone (Gallard Schlesinger, Carle Place, NY) in dioxane (Fisher Scientific Company, Pittsburgh, PA) was added dropwise while the pH was maintained at 9.0 by addition of 5% Na2CO3. After stirring for 2 h, the mixture was passed through a 2.4 X 20-cm column of Sephadex G-25 (Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated with phosphate-buffered saline, pH 7.4 (PBS). The conjugated material in the void volume was concentrated by negative pressure dialysis, and the protein content determined by the Micro-Kjeldahl method. The resulting picryl-Ascaris (Pic-Asc)' and oxazolone-Ascaris (Ox-Asc) conjugates contained 1.1 X l0-' and 5 X l0-7 mol of hapten/ mg of protein, respectively. Picryl (Pic) and oxazolone (Ox) haptens were conjugated to human serum albumin (Pic-HSA and Ox-HSA) in a manner similar to that described above.
Immunization procedures. Serum rich in IgE antibody to the haptenprotein conjugates Pic-Asc or Ox-Asc was obtained by a modification of techniques described previously (22) . Briefly, 6-8 guinea pigs per group received an intraperitoneal injection of 250 mg/kg of cyclophosphamide (Mead Johnson, Evansville, IN) 2 d before primary intraperitoneal immunization with 1 ug ofconjugate adsorbed to 1 mg ofAl(OH)3 (alum) in 1 ml of normal saline. Every month thereafter for 5 mo, a similar dose of antigen in alum was given intraperitoneally. 7 d after antigen injection in months 3, 4, and 5, the animals were bled daily for 3 d by cardiac puncture. At the end of 5 mo, the animals were exsanguinated. The sera was stored in aliquots at -90°C until time of use.
Serum rich in IgG, antibody to ovalbumin (OA), Pic-guinea pig albumin, or Ox-guinea pig albumin was obtained with the immune deviation procedure as described previously (25) . In this procedure, separate groups of guinea pigs were given a primary intraperitoneal immunization with 10 ,g of the respective antigen in Alum (1 mg Heavy chain-specific anti-guinea pig IgG, was prepared by passing an 18% Na2SO4 fraction ofthe rabbit antiserum through the IgG2 affinity column. The gamma globulin eluate was concentrated by negative pressure dialysis to 20 mg/ml and tested for heavy chain specificity by immunodiffusion against guinea pig IgG, and IgG2 (both at 3 mg/ml). Only one precipitin band to IgG, was noted.
Anti-IgG, affinity columns were prepared by linking 6 ml (17 mg/ ml) of the heavy chain-specific anti-IgG, to 100 g of Sepharose 4B with cyanogen bromide (88% coupling efficiency). Upon completion of the coupling procedure, the Sepharose was treated with ethanolamine and washed with low and high pH buffer solutions as described above.
IgG, was removed from guinea pig serum containing IgE antibody by slowly (1.5-2 h) passing the serum through an anti-IgG, affinity column at 4°C. The material passing through the column was concentrated to the original serum volume, and tested for residual IgG, antibody by immunodiffusion against the rabbit anti-IgG, and by enzyme-linked immunosorbent assay (ELISA). IgE antibody activity in this fraction was measured by using passive cutaneous anaphylaxis (PCA). The column was then washed thoroughly with 10 mM PBS, pH 7.4. IgG, bound to the affinity column was eluted with 10 ml of 0.2 M sodium carbonate (Na2CO3), pH 11.3, which was subsequently removed from the preparation by dialysis against PBS.
PCA. PCA antibody titrations were performed as described by Ovary (28) . Tenfold dilutions of the serum (in PBS) to be tested were made in test tubes and 0.1 ml of each dilution was injected intradermally into the flank skin of 300-g guinea pigs. A sensitization period of 4 h or 7 d was employed, and PCA reactions were developed by injecting intravenously I ml of 0.5% Evans Blue containing 1 mg of antigen. The PCA titer was taken as the highest dilution of antiserum giving a 6 X 6-mm blue reaction on the reflected skin surface in at least 3 of 4 recipients (24, 28) . Heat sensitivity of the PCA antibody activity was determined by incubating antisera at 560C for 4 h before performing dilutions for the PCA titration.
Quantitation and immunochemical identification ofguinea pig IgG1.
A modification of a previously described ELISA method (29) (31, 32) .
Each strip was suspended vertically in a 10-ml water-jacketed (37-38°C) tissue bath containing a physiological salt solution ofthe following composition: NaCl, 118 mM; KCI, 4.7 mM; CaCl2. 2H20, 2.5 mM; MgCl2*6H20, 0.5 mM; NaH2PO4-H20, I mM; NaHCO3, 25 mM; glucose, 11 mM. The solution bathing the tissue and the stock salt solution were gassed with a mixture ofoxygen (95%) and carbon dioxide (5%). Initial tensions on the tracheal and parenchymal strips were adjusted to 5 and 2 g, respectively, and maintained at these levels throughout a 90-120-min equilibration period. Changes in tension were recorded via force transducers (FT-03) on a Grass model SD or 7C polygraph. When adsorbing IgG, from IgE-rich serum, 50 ml of antiIgG, affinity column was underloaded with 4 ml of immune serum to obtain complete adsorption ofIgG, antibody. Material passing through such a column was concentrated to the original starting volume (4 ml) and tested for the presence ofIgE antibody by evaluating PCA activity in heated (560C X 4 h) and nonheated samples. In Fig. 1 , it can be observed that unadsorbed antiserum (heated or nonheated) produced significant PCA titers when a 4-h sensitization period was used, and had some heat-stable PCA activity when a 7-d sensitization period was used. This suggests the presence of IgG, antibody that is heat insensitive and also IgE antibody that is heat sensitive. Column-adsorbed serum retained PCA activity at 4-h and 7-d skin sensitization periods and this PCA activity was completely heat-labile (Fig.  1) . Accordingly, our adsorbed serum contains PCA activity that is due to IgE and not IgG, antibody, and this is as we have described previously (22) . The The lower limit of detection of IgGI in the ELISA was 10-20 ng/ml. The concentration of IgG, in unadsorbed IgE-rich serum was found to be 500-1,100 ,ug/ml. When this serum was depleted of IgG, by passage through the anti-IgGI affinity column, IgG, levels were consistently <20 ng/ml. All columnadsorbed sera were assayed similarly before being used in any study. antigen of 60-70% ( Fig. 2 and Table I ). While doses of 2 and 6 mg/kg (n = 6) of IgG, occasionally resulted in slightly larger responses (82±6%), the remainder of the study was conducted using 1 mg/kg of IgG, to passively sensitize the animals. Table I . Adsorbed IgE-rich serum containing <20 ng/ml of IgGI antibody (ELISA) was administered in doses of 1-15 ml/kg at 1, 4, or 7 d prior to isolation of the tracheal and parenchymal strips. A dose of 3 ml/kg (n = 6) was found to optimally sensitize the tissues and resulted in maximum responses to antigen (Pic-HSA or Ox-HSA; data shown only for Ox-HSA) of -40-60% ( Fig. 3 and Table I ). Contractile responses were similar when examined at all three time periods after serum administration. Usually, tissues isolated from animals sensitized with <3 ml/kg contracted 10-30% at maximum antigen concentrations. Doses >3 ml/kg did not result in an increase in the maximum antigen-provoked contractions. Contractions to the antigens were not observed when guinea pigs were injected with serum taken from unimmunized animals (3 ml/kg, 1 d), anti-hapten serum obtained from animals immunized for IgGI production and depleted of IgG1 by an antiIgGI affinity column (3 ml/kg, 1 d), or with IgG2 purified from anti-hapten serum (30 mg/kg, 1 d) . Furthermore, neither Pic-HSA nor Ox-HSA caused contractions of strips taken from animals not passively sensitized with antibody. The specificity of the responses was further verified by the demonstration that contractions could not be elicited to an extraneous antigen (OA) in tissues taken from animals sensitized with anti-hapten IgG, or IgE.
Heat sensitivity ofIgE-mediated, antigen-induced pulmonary contractions. Heat treatment (56°C X 4 h) of anti-Pic IgE-rich serum after adsorption with anti-IgG1 linked to Sepharose resulted in a marked reduction in the contractile responses to antigen in the guinea pig tissues. Peak contractions to Pic-HSA in the trachea and parenchyma were 49±6 and 42±7% of maximum, respectively, when the tissues were taken from animals receiving 3 ml/kg of unheated adsorbed serum (n = 3). The respective values were 19±7 and 18±6% of maximum when animals received an equal dose of heated, adsorbed serum (n = 5). Similar heat treatment of purified IgG, anti-hapten antibody (1 mg/kg, 1 d) did not alter the contractile response to antigen (n = 4).
Inhibition ofpositive sensitization. Having established that two antigen-specific factors in guinea pig serum can sensitize pulmonary smooth muscle for a contractile response on exposure to antigen, we sought to determine if these antibody-mediated responses could be inhibited by IgG, of an extraneous specificity.
Results of inhibition experiments by using purified guinea pig anti-OA IgG1 as blocking antibody are illustrated in Figs. 2-4 and summarized in Table I . There was substantial inhibition of the ability of Ox-HSA to contract tissues taken from animals passively sensitized with purified anti-Ox IgG, antibody (1 mg/kg, 1 d) after administration of 9-15 mg/kg of anti-OA IgG1 (Fig. 2 and Table I ). Doses of 3 and 6 mg/kg of anti-OA did not alter contractions to Ox-HSA. Doses of 50 and 100 mg/ kg completely abolished contraction in four animals sensitized with 1 mg/kg of anti-Ox IgGI antibody. At the end of each experiment, the tracheal and parenchymal strips were exposed to OA (10-1 mg/ml) and substantial contractions were observed.
In contrast, doses of 50 and 100 mg/kg of anti-OA IgG, given before either unadsorbed or adsorbed (<20 ng IgGI-ELISA)
IgE-rich anti-Ox serum (3 ml/kg) did not result in a change in the dose-response curves to the antigen Ox-HSA (Figs. 3 and  4 and Table I ).
In an additional experiment, the IgG1 anti-Ox antibody adsorbed from IgE-rich serum was desorbed from the anti-IgG1 affinity column and its identity confirmed by immunoelectro- Since there have been no myeloma proteins described in the guinea pig, IgE antibody can be defined only by characteristics it has in common with IgE from other species: PCA activity after a prolonged sensitization period in skin, loss ofPCA activity after heating or reduction and alkylation of the antibody, and passage of PCA activity through an affinity chromatography column that removes IgG1 antibody (22, 28 Since we have demonstrated that IgE antibody can sensitize guinea pig pulmonary tissues for antigen-induced contraction, this system can now be further examined as a possible model for IgE-mediated events in the human lung. In our studies, there was little difference in antigen sensitivity or maximum antigeninduced contraction between tracheal and parenchymal strips or between IgGj-and IgE-mediated contractions. However, this does not provide information about mediators released or cell types activated by antigen. Furthermore, the magnitude of desensitization occurring during cumulative antigen administration cannot be ascertained from these studies. Preliminary work has suggested differences in mediator release between IgG, and IgEsensitized guinea pig pulmonary tissues (19) (20) (21) 37) . Additional studies will be needed for a proper comparison of IgE-mediated events in guinea pig and human lung.
